explore -WSS

explore

author：hotspot 2025-09-30 12:10:22 - browse：8

Adam's take main illustration — Molly Ferguson/STAT

Cytokinetics was founded 26 years ago but has not yet developed a drug successfully to approval. That makes Tuesday’s Food and Drug Administration decision on its treatment for heart failure a big deal — except nearly everyone, even investors who own Cytokinetics — hopes the agency rules against it.

Hoping the FDA rejects the Cytokinetics drug, called omecamtiv mecarbil, is a relatively uncommon, up-is-down, down-is-up situation, but it makes sense in this case because the business and science of the drug are not aligned.

Consider: Cytokinetics shares rose in December when an outside group of experts convened by the FDA to examine omecamtiv’s benefits and risks recommended against the medicine’s approval. On Tuesday, the FDA is most likely to heed that advice and turn down the company’s marketing application.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： In age of alternative facts, a scholarly course on calling out crap
Next article： Drinking less cuts risk of oral cavity, esophageal cancer: Report

leisure time

entertainment

WSS

Christmas in the PICU brings some surprising joy

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

Illinois to ban advertising for guns allegedly marketed to kids and militants

How to keep neuroscience’s past racism from being its future

Appeals court upholds Josh Duggar's conviction for downloading child sex abuse images

SEC charges former device maker CEO with $41 million fraud

hotspot

explore

knowledge

Drug repurposing or repositioning? The language matters

More people are opting for early dinners since the pandemic, says OpenTable CEO Debby Soo

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Bristol Myers buys into radiopharmaceuticals with RayzeBio

Hollywood unions extend contract negotiations for actors

Israel demolishes home of alleged Palestinian attacker, fueling West Bank tensions

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Thousands in Haiti march to demand safety from violent gangs as killings and kidnappings soar

After affirmative action ruling, medical educators look to 'holistic review'

Christmas in the PICU brings some surprising joy

leisure time

Grail spinoff by Illumina should end disastrous merger attempt

CRISPR gene editing developments we’re watching in 2024

What STAT readers think about the FDA and patient advocacy

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

Can sheer will power keep patients alive in their dying hours?

Drinking less cuts risk of oral cavity, esophageal cancer: Report

entertainment

leisure time

entertainment

focus